Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorder.
John J MarianiMartina PavlicovaCale BasarabaAgnieszka Mamczur-FullerDaniel J BrooksAdam BisagaKenneth M CarpenterEdward V NunesFrances R LevinPublished in: Alcoholism, clinical and experimental research (2021)
Gabapentin treatment rapidly titrated to a dosage of 3600 mg/day is associated with a reduction in the proportion of HDD per week and an increase in PDA per week in actively drinking outpatients with AUD. High-dose gabapentin is potentially a feasible approach to treating AUD and deserving of further study.